title: Predictive genes in adjacent normal tissue are preferentially altered by sCNV during tumorigenesis in liver cancer and may rate limiting.
abstract: BACKGROUND
  In hepatocellular carcinoma (HCC) genes predictive of survival have been found in both adjacent normal (AN) and tumor (TU) tissues. The relationships between these two sets of predictive genes and the general process of tumorigenesis and disease progression remains unclear.
  
  
  RESULTS
  Here we have investigated HCC tumorigenesis by comparing gene expression, DNA copy number variation and survival using ∼250 AN and TU samples representing, respectively, the pre-cancer state, and the result of tumorigenesis. Genes that participate in tumorigenesis were defined using a gene-gene correlation meta-analysis procedure that compared AN versus TU tissues. Genes predictive of survival in AN (AN-survival genes) were found to be enriched in the differential gene-gene correlation gene set indicating that they directly participate in the process of tumorigenesis. Additionally the AN-survival genes were mostly not predictive after tumorigenesis in TU tissue and this transition was associated with and could largely be explained by the effect of somatic DNA copy number variation (sCNV) in cis and in trans. The data was consistent with the variance of AN-survival genes being rate-limiting steps in tumorigenesis and this was confirmed using a treatment that promotes HCC tumorigenesis that selectively altered AN-survival genes and genes differentially correlated between AN and TU.
  
  
  CONCLUSIONS
  This suggests that the process of tumor evolution involves rate-limiting steps related to the background from which the tumor evolved where these were frequently predictive of clinical outcome. Additionally treatments that alter the likelihood of tumorigenesis occurring may act by altering AN-survival genes, suggesting that the process can be manipulated. Further sCNV explains a substantial fraction of tumor specific expression and may therefore be a causal driver of tumor evolution in HCC and perhaps many solid tumor types.
authors.affiliation: Rosetta Inpharmatics, LLC, Seattle, Washington, United States of America. john.lamb@pfizer.com
authors.forename: John R
authors.initials: JR
authors.lastname: Lamb
authors.forename: Chunsheng
authors.initials: C
authors.lastname: Zhang
authors.forename: Tao
authors.initials: T
authors.lastname: Xie
authors.forename: Kai
authors.initials: K
authors.lastname: Wang
authors.forename: Bin
authors.initials: B
authors.lastname: Zhang
authors.forename: Ke
authors.initials: K
authors.lastname: Hao
authors.forename: Eugene
authors.initials: E
authors.lastname: Chudin
authors.forename: Hunter B
authors.initials: HB
authors.lastname: Fraser
authors.forename: Joshua
authors.initials: J
authors.lastname: Millstein
authors.forename: Mark
authors.initials: M
authors.lastname: Ferguson
authors.forename: Christine
authors.initials: C
authors.lastname: Suver
authors.forename: Irena
authors.initials: I
authors.lastname: Ivanovska
authors.forename: Martin
authors.initials: M
authors.lastname: Scott
authors.forename: Ulrike
authors.initials: U
authors.lastname: Philippar
authors.forename: Dimple
authors.initials: D
authors.lastname: Bansal
authors.forename: Zhan
authors.initials: Z
authors.lastname: Zhang
authors.forename: Julja
authors.initials: J
authors.lastname: Burchard
authors.forename: Ryan
authors.initials: R
authors.lastname: Smith
authors.forename: Danielle
authors.initials: D
authors.lastname: Greenawalt
authors.forename: Michele
authors.initials: M
authors.lastname: Cleary
authors.forename: Jonathan
authors.initials: J
authors.lastname: Derry
authors.forename: Andrey
authors.initials: A
authors.lastname: Loboda
authors.forename: James
authors.initials: J
authors.lastname: Watters
authors.forename: Ronnie T P
authors.initials: RT
authors.lastname: Poon
authors.forename: Sheung T
authors.initials: ST
authors.lastname: Fan
authors.forename: Chun
authors.initials: C
authors.lastname: Yeung
authors.forename: Nikki P Y
authors.initials: NP
authors.lastname: Lee
authors.forename: Justin
authors.initials: J
authors.lastname: Guinney
authors.forename: Cliona
authors.initials: C
authors.lastname: Molony
authors.forename: Valur
authors.initials: V
authors.lastname: Emilsson
authors.forename: Carolyn
authors.initials: C
authors.lastname: Buser-Doepner
authors.forename: Jun
authors.initials: J
authors.lastname: Zhu
authors.forename: Stephen
authors.initials: S
authors.lastname: Friend
authors.forename: Mao
authors.initials: M
authors.lastname: Mao
authors.forename: Peter M
authors.initials: PM
authors.lastname: Shaw
authors.forename: Hongyue
authors.initials: H
authors.lastname: Dai
authors.forename: John M
authors.initials: JM
authors.lastname: Luk
authors.forename: Eric E
authors.initials: EE
authors.lastname: Schadt
mesh_terms: D000328:Adult; D000368:Aged; D000818:Animals; D006528:Carcinoma, Hepatocellular / Q000235:genetics*; D045744:Cell Line, Tumor; D002878:Chromosomes, Human, Pair 1 / Q000235:genetics; D056915:DNA Copy Number Variations; D005260:Female; D020869:Gene Expression Profiling; D053263:Gene Regulatory Networks; D006801:Humans; D008099:Liver / Q000378:metabolism* / Q000473:pathology; D008113:Liver Neoplasms / Q000235:genetics*; D008297:Male; D051379:Mice; D008822:Mice, Transgenic; D008875:Middle Aged; D008957:Models, Genetic; D020411:Oligonucleotide Array Sequence Analysis; D019859:Proto-Oncogene Proteins c-met / Q000235:genetics; D012044:Regression Analysis
chemical_list: D019859:Proto-Oncogene Proteins c-met